Food and Drug Administration, HHS.
Final rule; technical amendment.
The Food and Drug Administration (FDA) published a final rule in the Federal Register of October 31, 2003 (68 FR 62007). The final rule classified the endotoxin assay into class II (special controls). The agency classified the device into class II (special controls) in order to provide reasonable assurance of safety and effectiveness of the device. FDA is amending the agency's regulations to redesignate the section number listed in the Code of Federal Regulations (CFR) from § 866.3610 to § 866.3210.
This rule is effective September 7, 2005.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Freddie M. Poole, Center for Devices and Radiological Health (HFZ-440), Food and Drug Administration, 2098 Gaither Rd., Rockville, MD 20850, 240-276-0496 ext. 1111.End Further Info End Preamble Start Supplemental Information
FDA has found that the endotoxin assay regulation does not reflect the correct section number listed in the CFR. Accordingly, FDA is amending the regulation in § 866.3610 (21 CFR 866.3610) to correct the error by redesignating the section number from § 866.3610 to 866.3210.Start List of Subjects
List of Subjects in 21 CFR Part 866End List of Subjects Start Amendment Part
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs,End Amendment Part Start Part
PART 866—IMMUNOLOGY AND MICROBIOLOGY DEVICESEnd Part Start Amendment Part
1. The authority citation forEnd Amendment Part
2. Section 866.3610 is redesignated as § 866.3210.End Amendment Part Start Signature
Dated: August 26, 2005.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. 05-17645 Filed 9-6-05; 8:45 am]
BILLING CODE 4160-01-S